Skip to main content

Animations

MJFF Publications

1451 - 1460 of 8404 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13678
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12966
    Best OA location URL:
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00451-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-36058-2
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: NLRP3 inflammasome in neurodegenerative disease
    Journal Name: Translational Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.trsl.2022.08.006
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202201607
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00457-5
    Citation Count: 33
  • Summary Details
    OPEN
    Title: In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac445
    Citation Count: 24
  • Summary Details
    OPEN
    Title: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
    Journal Name: Frontiers in Molecular Biosciences
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.